{"ABT": {"Ticker": "ABT", "Company": "Abbott Laboratories", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$117"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS"], "Price_Target": 117.0}, "AVB": {"Ticker": "AVB", "Company": "AvalonBay Communities", "Sector": "Real Estate", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$184"}, {"Date": "2023-01-17", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$186 to $190"}, {"Date": "2023-01-04", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$194 to $179"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Truist", "Deutsche Bank", "Wells Fargo"], "Price_Target": 184.33}, "BBWI": {"Ticker": "BBWI", "Company": "Bath & Body Works Inc.", "Sector": "Consumer Discretionary", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2023-03-17", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$50 to $48"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$55 to $46"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Argus", "Citigroup", "UBS", "Wells Fargo"], "Price_Target": 47.0}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$43"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$55"}, {"Date": "2023-01-05", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$66 to $55"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Morgan Stanley", "Raymond James", "UBS", "BofA Securities"], "Price_Target": 51.0}, "BSX": {"Ticker": "BSX", "Company": "Boston Scientific", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$57"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS"], "Price_Target": 57.0}, "CCL": {"Ticker": "CCL", "Company": "Carnival Corporation", "Sector": "Consumer Discretionary", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Upgrade", "Organization": "Susquehanna", "Rating_Change": "Neutral to Positive", "Target_Change": "$11"}, {"Date": "2023-03-28", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$9"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Susquehanna", "Wells Fargo"], "Price_Target": 10.0}, "DE": {"Ticker": "DE", "Company": "Deere & Co.", "Sector": "Industrials", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Daiwa Securities", "Rating_Change": "Outperform", "Target_Change": "$440"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Daiwa Securities"], "Price_Target": 440.0}, "DXCM": {"Ticker": "DXCM", "Company": "DexCom", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$142"}, {"Date": "2023-01-26", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$121"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wolfe Research", "UBS"], "Price_Target": 131.5}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$84"}, {"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$97 to $78"}, {"Date": "2023-02-06", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Underperform", "Target_Change": "$95 to $66"}, {"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$95 to $80"}], "Score": -1.8, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Bernstein", "UBS", "Raymond James", "Piper Sandler", "Wells Fargo"], "Price_Target": 77.0}, "EQR": {"Ticker": "EQR", "Company": "Equity Residential", "Sector": "Real Estate", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$62"}, {"Date": "2023-01-17", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$68"}, {"Date": "2023-01-11", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$58"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Credit Suisse", "BTIG Research", "Truist", "Wells Fargo"], "Price_Target": 62.67}, "ESS": {"Ticker": "ESS", "Company": "Essex Property Trust", "Sector": "Real Estate", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$208"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wells Fargo"], "Price_Target": 208.0}, "IPG": {"Ticker": "IPG", "Company": "Interpublic Group", "Sector": "Communication Services", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$40"}, {"Date": "2023-02-10", "Rating": "Downgrade", "Organization": "MoffettNathanson", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$36 to $37"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$22 to $36"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["MoffettNathanson", "BofA Securities", "Exane BNP Paribas"], "Price_Target": 37.67}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$278"}, {"Date": "2023-03-23", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["UBS", "William Blair"], "Price_Target": 278.0}, "IVZ": {"Ticker": "IVZ", "Company": "Invesco", "Sector": "Financials", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Underperform to Neutral", "Target_Change": "$14.50 to $15"}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$19 to $20"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Credit Suisse", "UBS"], "Price_Target": 17.5}, "JNJ": {"Ticker": "JNJ", "Company": "Johnson & Johnson", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$164"}, {"Date": "2023-03-01", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$161"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Guggenheim", "UBS"], "Price_Target": 162.5}, "MPC": {"Ticker": "MPC", "Company": "Marathon Petroleum", "Sector": "Energy", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$132 to $150"}, {"Date": "2023-03-28", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$137 to $149"}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$133 to $160"}, {"Date": "2023-03-09", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$165"}, {"Date": "2023-03-03", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$134 to $157"}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$125 to $133"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan", "Jefferies", "UBS", "Goldman", "Mizuho"], "Price_Target": 152.33}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Sell", "Target_Change": "$127 to $79"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$102 to $89"}], "Score": -2.5, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "E", "Analists": ["RBC Capital Mkts", "UBS"], "Price_Target": 84.0}, "MAA": {"Ticker": "MAA", "Company": "Mid-America Apartments", "Sector": "Real Estate", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$156.50"}, {"Date": "2023-03-14", "Rating": "Downgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Outperform to Sector Perform", "Target_Change": ""}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$176 to $167"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$160"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Credit Suisse", "Truist", "Scotiabank", "Wells Fargo"], "Price_Target": 163.5}, "OMC": {"Ticker": "OMC", "Company": "Omnicom Group", "Sector": "Communication Services", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Underperform to Neutral", "Target_Change": "$96"}, {"Date": "2023-02-08", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$85 to $95"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Morgan Stanley", "Exane BNP Paribas"], "Price_Target": 95.5}, "ROST": {"Ticker": "ROST", "Company": "Ross Stores", "Sector": "Consumer Discretionary", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Neutral to Sell", "Target_Change": ""}, {"Date": "2023-03-22", "Rating": "Upgrade", "Organization": "Loop Capital", "Rating_Change": "Hold to Buy", "Target_Change": "$105 to $115"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Loop Capital"], "Price_Target": 115.0}, "SYK": {"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$287"}, {"Date": "2023-01-25", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight", "Target_Change": ""}, {"Date": "2023-01-09", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$240 to $284"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["KeyBanc Capital Markets", "UBS", "RBC Capital Mkts"], "Price_Target": 285.5}, "HIG": {"Ticker": "HIG", "Company": "The Hartford", "Sector": "Financials", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$84"}, {"Date": "2023-01-20", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$77"}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$85"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$84"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "BMO Capital Markets", "Goldman"], "Price_Target": 82.5}, "HSY": {"Ticker": "HSY", "Company": "The Hershey Company", "Sector": "Consumer Staples", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$230 to $255"}, {"Date": "2023-03-24", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$222 to $235"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$245"}, {"Date": "2023-01-03", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Evercore ISI", "Mizuho", "Wells Fargo"], "Price_Target": 245.0}, "UDR": {"Ticker": "UDR", "Company": "UDR", "Sector": "Real Estate", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$44.50"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wells Fargo"], "Price_Target": 0}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2023-03-29", "Rating": [{"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Sell", "Target_Change": "$112"}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$135 to $145"}, {"Date": "2023-01-09", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$125 to $141"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$144"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$130"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["RBC Capital Mkts", "UBS", "Raymond James", "Evercore ISI", "Piper Sandler"], "Price_Target": 134.4}}